James T. Parsons's most recent trade in Oncolytics Biotech, Inc. was a trade of 30,000 Stock Option done . Disclosure was reported to the exchange on June 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncolytics Biotech Inc | James T. Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option | |
| Oncolytics Biotech Inc | James T. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 11 Mar 2026 | 10,000 | 41,849 (0%) | 0% | 1.0 | 10,300 | Common Shares |